Diabetes Information [Return To Home Page]

Type 1 and Type 2 Diabetes


Diabetes affects the manner in which the body handles digested carbohydrates. If neglected, diabetes can cause serious health complications, ranging from blindness to kidney failure.

Approximately 8% of the population in the United States has diabetes. This means that approximately 16 million people have been diagnosed with the disease, based only on national statistics. The American Diabetes Association estimates that diabetes accounts for 178,000 deaths, 54,000 amputees, and 12,000-24,000 cases of blindness annually. Blindness is 25 times more common among diabetic patients compared to nondiabetics. It is proposed that by the year 2010, diabetes will exceed both heart disease and cancer as the leading cause of death through its many complications.

Diabetics have a high level of blood glucose. The blood sugar level is regulated by insulin, a hormone produced by the pancreas, which releases it in response to food consumption. Insulin causes the cells of the body to take in glucose from the blood. The glucose is used as fuel for cellular functions.

Diagnostic standards for diabetes have been fasting plasma glucose levels greater than 140 mg/dL on two occasions and plasma glucose greater than 200 mg/dL following a 75-gram glucose load. More recently, the American Diabetes Association lowered the criteria for a diabetes diagnosis to fasting plasma glucose levels equal to or greater than 126 mg/dL. Fasting plasma levels outside the normal limit require additional tests, usually by repeating the fasting plasma glucose test and (if indicated) giving the patient an oral glucose tolerance test.

The symptoms of diabetes include excessive urination, excessive thirst and hunger, sudden weight loss, blurred vision, delay in healing of wounds, dry and itchy skin, repeated infections, fatigue and headache. These symptoms, while suggestive of diabetes, may be due to other reasons also.

There are two different types of diabetes.

Type I Diabetes (juvenile diabetes or insulin-dependent diabetes): The cause of type I diabetes is caused by pancreatic inability to produce insulin. It is responsible for 5-10% of cases of diabetes. The pancreatic Islet of Langerhans cells, which secrete the hormone, are destroyed by the body's own immune system, probably because it mistakes them for a virus. Viral infections are thought to be the trigger that sets off this auto-immune disease. It is more common in caucasians and runs in families.

If untreated, death occurs within a few months of the onset of juvenile diabetes, as the cells of the body starve because they no longer receive the hormonal prompt to take in glucose. While most Type I diabetics are young (hence the term Juvenile Diabetes), the condition can develop at any age. Autoimmune diabetes can be definitely diagnosed by a blood test which shows the presence of anti-insulin/anti-islet-cell antibodies.

Type II Diabetes (non insulin dependent diabetes or adult onset diabetes): This diabetes is a result of body tissues becoming resistant to insulin. It accounts for 90-95% of cases. Often the pancreas is producing more than average amounts of insulin, but the cells of the body have become unresponsive to its effect due to the chronically high level of the hormone. Eventually the pancreas may exhaust its over-active secretion of the hormone, and insulin levels fall to below normal.

A tendency towards Type II diabetes is hereditary, but it is unlikely to develop in normal-weight individuals eating a low- or moderate-carbohydrate diet. Obese, sedentary individuals who eat poor-quality diets based on refined starch, which constantly activates pancreatic insulin secretion, are prone to develop insulin resistance. Native peoples such as North American Indians whose traditional diets did not include refined starch until its recent introduction by Europeans have extremely high rates of diabetes, up to 5 times the rate of caucasians. Blacks and hispanics are also at higher risk. Though Type II diabetes is not fatal within a matter of months, it can lead to health complications over several years and cause severe disability and premature death. As with Type I diabetes, the condition is found primarily in one age group, in this case people over 40 (which is why it is often termed Adult Onset); however, with the rise in childhood and teenage obesity, it is appearing in children as well.

If neglected, diabetes can lead to life-threatening complications such as kidney damage (nephropathy), heart disease, nerve damage (neuropathy), retinal damage and blindness(retinopathy), and hypoglycemia (drastic reduction in glucose levels). Diabetes damages blood vessels, especially smaller end-arteries, leading to severe and premature atherosclerosis. Diabetics are prone to foot problems because neuropathy, which affects approximately 10% of patients, causes their feet to lose sensation. Foot injuries, common in day-to-day living, go unnoticed, and these injuries do not heal because of poor circulation through the small arteries in the foot. Gangrene and subsequent amputation of toes or feet is the consequence for many elderly patients with poorly-controlled diabetes. Usually these sequelae appear earlier in Type I than Type II diabetes, because Type II patients have some of their own insulin production left to buffer changes in blood sugar levels.

Type I diabetes is a serious disease and there is no permanent cure for it. However, the symptoms can be controlled by strict dietary monitering and insulin injections. Implanted pumps which release insulin immediately in response to changes in blood glucose are in the testing stages.

In theory, since it caused by diet, Type II diabetes should be preventable and manageable by dietary changes alone, but in practice many diabetics (and many obese people without diabetes) find it personally impossible to lose weight or adhere to a healthy diet. Therefore they are frequently treated with drugs which restore the body's response to insulin, and in some cases injections of insulin.

Please note that this article is not a subsitute for medical advice. If you suspect you have diabetes or are in a high risk group, please see your doctor.

For more information, please visit our site, http://www.diabetes-testing-2006.info

Frank Vanderlugt
http://www.diabetes-testing-2006.info


MORE RESOURCES:


TopNews United States

Novartis drugs fail to prevent diabetes in the overweight
Xinhua
BEIJING, March 15 (Xinhuanet) -- Novartis AG's (NVS) two drugs have failed to prevent diabetes and the problems it causes in the overweight with poor sugar ...
Drugs in pre-diabetics do little to slow progression to diabetes or to heart ...Los Angeles Times (blog)
Search for Better Diabetes Therapy Falls ShortWall Street Journal
Soy products beat drugs for type 2 diabetes prevention?Food Consumer
BusinessWeek -TopNews United States -Visit Bulgaria
all 20 news articles »


FDA wants label information on diabetes injection
MarketWatch
Byuderon is a once-weekly formulation of exenatide, the active ingredient in Byetta which is used in Type 2 diabetes. In the complete response letter, ...
Byetta LARS: How the FDA's Analysis Paralysis May Aid AmylinSeeking Alpha (blog)
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for ...PR Newswire (press release)
FDA finds flaws at Amylin plantCincinnati Business Courier
Financial News USA (press release)
all 18 news articles »


Forbes (blog)

No heart benefit seen with fibrates in diabetics
Reuters
The study run by the National Institutes of Health, dubbed Accord, aimed to see if the dual-drug therapy could reduce cardiovascular events in diabetes ...
Abbott's TriCor Shows No Benefit For Diabetics In StudyWall Street Journal
Abbott's TriCor With Statin Fails to Cut Diabetic Heart RiskBusinessWeek
ACC: FDA Announces Review of ACCORD DataMedPage Today
Forbes (blog) -PR Newswire (press release) -Benzinga
all 69 news articles »


BBC News

No quick drug fix for high diabetes risk
BBC News
Two key treatments do not halt diabetes in people with early signs of the disease, a large study has found. Researchers said the results showed the only way ...
Workplace fruit - helping keep your diet on trackFruitful Office - Office Fruit News Site (blog)

all 7 news articles »


Effect of Valsartan/Nateglinide on the Incidence of Diabetes and ...
Cardiosource
Study Question: Does use of short-acting insulin secretagogues and/or rennin-angiotensin-blockers reduce the risk of diabetes or cardiovascular (CV) events ...
NAVIGATOR: Valsartan slowed progression to diabetes, no effect on CV eventsEndocrine Today
Navigating the Choices for Diabetes PreventionNew England Journal of Medicine (subscription)
NAVIGATOR Shows Valsartan Delayed Progression to Type 2 Diabetes in At-Risk ...PR Newswire (press release)
MedPage Today -RTT News
all 22 news articles »


Swiss stocks - Factors to watch on March 15
Reuters
The diabetes drug Starlix failed to reduce progression to the disease or cut down on serious heart problems in patients at high risk for both diabetes and ...

and more »


Psychologist helps people cope with diabetes
GoErie.com
D., a psychologist who focuses on helping people with diabetes cope with the stress of having the disease. Studies have shown that people with diabetes have ...
Psychologist helps people cope with diabetesGoErie.com

all 2 news articles »


KolkataObserver.com

Aggressive BP control not effective, possibly harmful, in patients with diabetes
Endocrine Today
ATLANTA – Tight systolic blood pressure control in high-risk patients with diabetes appears to be no more effective in avoiding myocardial infarction, ...
Study: 'Ideal' Blood Pressure Level May Be Too Low For DiabeticsAHN | All Headline News
ACC: Pushing Blood Pressure Too Low May be HarmfulMedPage Today
INVEST: Mortality hazard with lowest blood pressures in diabetics with CAD?TheHeart.Org

all 22 news articles »


Lowering BP risky for patients with diabetes, heart disease
Sify
A University of Florida researcher has urged caution in reducing blood pressure in patients with diabetes and coronary disease. ...


Google News






home | site map
© 2006